Organic Letters
Letter
HIV-1 strains. Bioorg. Med. Chem. Lett. 2007, 17, 1956−1960. (b) Li,
Q.; Li, T.; Woods, K. W.; Gu, W.-Z.; Cohen, J.; Stoll, V. S.; Galicia,
T.; Hutchins, C.; Frost, D.; Rosenberg, S. H.; Sham, H. L.
Benzimidazolones and indoles as non-thiol farnesyltransferase
inhibitors based on tipifarnib scaffold: synthesis and activity. Bioorg.
Med. Chem. Lett. 2005, 15, 2918−2922. (c) Terefenko, E. A.; Kern, J.;
Fensome, A.; Wrobel, J.; Zhu, Y.; Cohen, J.; Winneker, R.; Zhang, Z.;
Zhang, P. SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as
progesterone receptor antagonists. Bioorg. Med. Chem. Lett. 2005, 15,
3600−3603. (d) Lewis, J. A.; Scott, S. A.; Lavieri, R.; Buck, J. R.;
Selvy, P. E.; Stoops, S. L.; Armstrong, M. D.; Brown, H. A.; Lindsley,
C. W. Design and synthesis of isoform-selective phospholipase D
(PLD) inhibitors. Part I: Impact of alternative halogenated privileged
structures for PLD1 specificity. Bioorg. Med. Chem. Lett. 2009, 19,
1916−1920. (e) Zaveri, N. T.; Jiang, F.; Olsen, C.; Polgar, W. E.; Toll,
L. Designing bifunctional NOP receptor−mu opioid receptor ligands
from NOP receptor-selective scaffolds. Part I. Bioorg. Med. Chem. Lett.
2013, 23, 3308−3313.
benzenesulfonyl radical A and selenium radical B. A then reacts
with o-diisocyanide 1a to deliver C. Intermediate C
subsequently reacts with B to give intermediate D through a
synergism process. The second addition of selenosulfonate 2a
to the other isocyanide affords intermediate E. The alcoholysis
of intermediate E gives F and 5. An intramolecular cyclization
process subsequently will occur and the final product 3a is
obtained, along with intermediate G. The diselenide 6 can be
obtained by homocoupling of B or G.
In summary, we have developed a facile method for the
synthesis of N-(carboselenoate) benzimidazolones via the
reaction of o-diisocyanoarenes with selenosulfonates under
metal-free conditions. The reaction is easy to handle and
proceeds smoothly with moderate to good yields.
ASSOCIATED CONTENT
* Supporting Information
■
S
́
(2) (a) Saidani, N.; Botte, C. Y.; Deligny, M.; Bonneau, A.-L.;
Reader, J.; Lasselin, R.; Merer, G.; Niepceron, A.; Brossier, F.; Cintrat,
J.-C.; Rousseau, B.; Birkholtz, L.-M.; Cesbron-Delauw, M.-F.;
The Supporting Information is available free of charge on the
́
Dubremetz, J.-F.; Mercier, C.; Vial, H.; Lopez, R.; Marechal, E.
Discovery of compounds blocking the proliferation of Toxoplasma
gondii and Plasmodium falciparum in a chemical space based on
piperidinyl-benzimidazolone analogs. Antimicrob. Agents Chemother.
Detailed experimental procedures, and characterization
2014, 58, 2586−2597. (b) van de Streek, J.; Bruning, J.; Ivashevskaya,
̈
Accession Codes
S. N.; Ermrich, M.; Paulus, E. F.; Bolte, M.; Schmidt, M. U. Structures
of six industrial benzimidazolone pigments from laboratory powder
diffraction data. Acta Crystallogr., Sect. B: Struct. Sci. 2009, B65, 200−
211. (c) Gordon, P. F.; Gregory, P. Organic Chemistry in Colour;
Springer: Berlin, 1987;. (d) Zollinger, H. Color Chemistry, 3rd
CCDC 1904577 contains the supplementary crystallographic
data for this paper. These data can be obtained free of charge
bridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
Edition; VHCA (Zu
2003.
̈
rich) and Wiley-VCH (Weinheim, Germany),
(3) (a) Wright, J. B. The chemistry of the benzimidazoles. Chem.
Rev. 1951, 48, 397−541. (b) Pike, K. G.; Finlay, M. R.; Fillery, S. M.;
Dishington, A. P. Preparation of morpholinopyrimidine derivatives for
treatment of proliferative disease. PCT WO 2007080382 A1, 2007.
(c) Wu, H.; Wu, D.; Huang, X.; Su, W. Method for synthesis of 2-
hydroxybenzimidazole. Chin. Patent No. CN 101209996 A, 2008.
(4) Ogino, Y.; Ohtake, N.; Nagae, Y.; et al. Design, syntheses, and
structure-activity relationships of novel NPY Y5 receptor antagonists:
2-{3-Oxospiro[isobenzofuran-1(3H),4’-piperidin]-1’-yl}benzimida-
zole derivatives. Bioorg. Med. Chem. Lett. 2008, 18, 5010−5014.
(5) (a) Kim, Y. J.; Varma, R. S. Microwave-assisted preparation of
cyclic ureas from diamines in the presence of ZnO. Tetrahedron Lett.
AUTHOR INFORMATION
Corresponding Authors
■
ORCID
Notes
̈
2004, 45, 7205−7208. (b) Zhang, M.; Imm, S.; Bahn, S.; Neubert, L.;
Neumann, H.; Beller, M. Efficient copper(II)-catalyzed trans-
amidation of non-activated primary carboxamides and ureas with
amines. Angew. Chem., Int. Ed. 2012, 51, 3905−3909. (c) Rekunge, D.
S.; Khatri, C. K.; Chaturbhuj, G. U. Sulfated polyborate-catalyzed
efficient and expeditious synthesis of (un)symmetrical ureas and
benzimidazolones. Tetrahedron Lett. 2017, 58, 4304−4307.
(6) (a) Fu, Y.; Baba, T.; Ono, Y. Carbonylation of o-phenylenedi-
amine and o-aminophenol with dimethyl carbonate using lead
compounds as catalysts. J. Catal. 2001, 197, 91−97. (b) Nale, D.
B.; Bhanage, B. M. Copper-catalyzed efficient synthesis of a 2-
benzimidazolone scaffold from 2-nitroaniline and dimethyl carbonate
via a hydrosilylation reaction. Green Chem. 2015, 17, 2480−2486.
(7) (a) Gabriele, B.; Salerno, G.; Mancuso, R.; Costa, M. Efficient
synthesis of ureas by direct palladium-catalyzed oxidative carbon-
ylation of amines. J. Org. Chem. 2004, 69, 4741−4750. (b) Wang, X.;
Ling, G.; Xue, Y.; Lu, S. Selenium-catalyzed reductive carbonylation of
2-nitrophenols to 2-benzoxazolones. Eur. J. Org. Chem. 2005, 2005,
1675−1679. (c) Qi, X.; Zhou, R.; Peng, J.-B.; Ying, J.; Wu, X.-F.
Selenium-catalyzed carbonylative synthesis of 2-benzimidazolones
from 2-nitroanilines with TFBen as the CO source. Eur. J. Org. Chem.
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We gratefully acknowledge the National Natural Science
Foundation of China (Nos. 21772137, 21542015, and
21672157), PAPD, the Project of Scientific and Technologic
Infrastructure of Suzhou (No. SZS201708), the Major Basic
Research Project of the Natural Science Foundation of the
Jiangsu Higher Education Institutions (No. 16KJA150002),
Postgraduate Research & Practice Innovation Program of
Jiangsu Province (No. KYCX17_1980), Soochow University,
and State and Local Joint Engineering Laboratory for Novel
Functional Polymeric Materials for financial support. We thank
Bei-Bei Liu in this group for reproducing the results of 3d, 3f,
3g, and 3m.
REFERENCES
■
(1) (a) Barreca, M. L.; Rao, A.; De Luca, L.; Iraci, N.; Monforte, A.-
M.; Maga, G.; De Clercq, E.; Pannecouque, C.; Balzarini, J.; Chimirri,
A. Discovery of novel benzimidazolones as potent non-nucleoside
reverse transcriptase inhibitors active against wild-type and mutant
(8) (a) Kimura, T.; Kamata, K.; Mizuno, N. A bifunctional tungstate
catalyst for chemical fixation of CO2 at atmospheric pressure. Angew.
D
Org. Lett. XXXX, XXX, XXX−XXX